J&J Must Lay Out Remediation Specifics To Regain Trust In OTCs – Expert
McNeil Consumer Healthcare continues on the long road back to full manufacturing strength and consumer confidence in its OTCs with an ongoing review of issues that have plagued the company with recalls.
More from Archive
More from Pink Sheet
• By
Ongoing questions about user fees exerting too much influence over the FDA could spawn a shift in the PDUFA structure when talks begin later this year.
• By
Vincenza Trivigno will take over as executive director from Raimund Bruhin, who is retiring after over seven years in the post.
• By
Stefan Oelrich, the newly-announced president of European pharma industry federation EFPIA says the EU pharma reform is “not an improvement on the status quo” in its current form.